Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of AKI
Timeframe: 30 days post-hospital admission
Cystatin C as indicator of mortality
Timeframe: 30 days post-hospital admission
Cystatin C as indicator of renal disease
Timeframe: 30 days post-hospital admission
Cystatin C as indicator of respiratory illness
Timeframe: 30 days post-hospital admission
Cystatin C as indicator of disease severity
Timeframe: 30 days post-hospital admission